Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs

Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs


's stock had its "neutral" rating reissued by research analysts at Goldman Sachs in a note issued to investors on Saturday, AnalystRatings.Net reports. They currently have a $56.00 target price on the stock, down from their previous target price of $60.00.



from Biotech News